Vascular endothelial growth factor inhibition is not an effective therapeutic strategy for relapsed or refractory multiple myeloma: a phase 2 study of pazopanib (GW786034).

Journal Article (Letter)

Full Text

Duke Authors

Cited Authors

  • Prince, HM; Hönemann, D; Spencer, A; Rizzieri, DA; Stadtmauer, EA; Roberts, AW; Bahlis, N; Tricot, G; Bell, B; Demarini, DJ; Benjamin Suttle, A; Baker, KL; Pandite, LN

Published Date

  • May 7, 2009

Published In

Volume / Issue

  • 113 / 19

Start / End Page

  • 4819 - 4820

PubMed ID

  • 19423744

Pubmed Central ID

  • 19423744

Electronic International Standard Serial Number (EISSN)

  • 1528-0020

Digital Object Identifier (DOI)

  • 10.1182/blood-2009-02-207209

Language

  • eng

Conference Location

  • United States